FDA panel fails to reach consensus on technical standards for stents
This article was originally published in Clinica
Executive Summary
The FDA's advisors on cardiovascular devices agreed last week that it would be a good idea to find ways to reduce the time it takes the agency to review cardiac stents. But with no votes taken, the panel provided few, if any, concrete proposals on how to proceed after a day-long brainstorming session on the topic.